Advertisement

Topics

Tempus Company Profile

03:09 EDT 19th June 2019 | BioPortfolio

Tempus is a technology company that is building the world’s largest library of molecular and clinical data and an operating system to make that data accessible and useful. We enable physicians to deliver personalized cancer care for patients through our interactive analytical and machine learning platform. We provide genomic sequencing services and analyze molecular and therapeutic data to empower physicians to make real-time, data-driven decisions. Our goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as we gather more data. For more information, visit tempus.com and follow us on Facebook (Tempus Labs) and Twitter (@TempusLabs). For more information on Eric Lefkofsky, visit lefkofsky.com.


News Articles [21 Associated News Articles listed on BioPortfolio]

Tempus Energys banbrytande domstolsbeslut banar vägen för lägre priser och renare energi ...

LONDON, November 19, 2018 /PRNewswire/ -- Innovatören Tempus Energy lyckas utmana ensidigheten för fossila bränslen på den brittiska elmarknaden Kundfinansierade subventioner på 5,6 miljarder pun...

La décision de justice historique de Tempus Energy ouvre la voie à des énergies plus propres ...

LONDRES, November 19, 2018 /PRNewswire/ -- L'entreprise innovante Tempus Energy conteste avec succès le parti pris pour les carburants fossiles du marché de l'énergie au Read more...

De baanbrekende gerechtelijke uitspraak voor Tempus Energy opent de deur voor lagere ...

LONDEN, November 19, 2018 /PRNewswire/ -- Innovator Tempus Energy betwist met succes de vooroordelen op het gebied van fossiele brandstof in het Verenigd Koninkrijk Door Read more...

Tempus Labs raises $70mm in Series C round

Tempus Labs Inc. raised $70mm through its Series C round co-led by New Enterprise Associates and Revolution Growth. The company, which is building a library of clinical and molecular data for personal...

Series D brings in $80mm for Tempus Labs

Tempus Labs Inc. (data-drive precision medicine for cancer) raised $80mm through its Series D round from new investors Kinship Trust and funds advised by T. Rowe Price, along with returning backer New...

Series F brings $200mm to Tempus Labs

AI and precision medicine firm Tempus Labs Inc. raised $200mm through its Series F round from investors including Baillie Gifford, Franklin Templeton, NEA, Novo Holdings, Revolution Growth, and funds ...

Data-Driven Precision Medicine Startup Tempus Lands $200M to Expand Into New Therapeutic Areas

Tempus, a leading technology company advancing precision medicine through the collection and analysis of molecular and clinical data, announced today an additional $200M financing at a value of $3.1 b...

Tempus Labs brings in $110mm through Series E round

Tempus Labs Inc. (AI-driven analytics and precision medicine for cancer) raised $110mm through its Series E round. Baillie Gifford, funds managed by T. Rowe Price, Revolution Growth, New Enterprise As...

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Preanalytical robustness of blood collection tubes with RNA stabilizers.

Background Efficient blood stabilization is essential to obtaining reliable and comparable RNA analysis data in preclinical operations. PAXgene (Qiagen, Becton Dickinson) and Tempus (Applied Biosystem...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Determine the Improvement in Activity Status/Quality of Life (QoL) of Patients With Rheumatoid Arthritis (RA) During Treatment With Lodotra (Prednisone)

Rheumatoid arthritis is the most common rheumatic disease with symptomatic morning stiffness which entails a quite essential restriction in the everyday life and in the life quality. This ...

Companies [1 Associated Companies listed on BioPortfolio]

Tempus

Tempus is a technology company that is building the world’s largest library of molecular and clinical data and an operating system to make that data accessible and useful. We...

More Information about "Tempus" on BioPortfolio

We have published hundreds of Tempus news stories on BioPortfolio along with dozens of Tempus Clinical Trials and PubMed Articles about Tempus for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tempus Companies in our database. You can also find out about relevant Tempus Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...


Corporate Database Quicklinks



Searches Linking to this Company Record